Slovenia to get Japanese drug for trials on Covid-19 patients
Ljubljana, 15 May - The government has accept an initiative to close an agreement with the UN Office for Project Services on the delivery of the Japanese anti-influenza medicine called favipiravir for clinical trials in treatment of Covid-19 patients.
Ljubljana
The Department of Infectious Diseases at the Ljubljana University Medical Centre (UKC) treating Covid-19 patients.
Photo: UKC Ljubljana
File photo
The rest of this news item is available to subscribers.
The news item consists of 1.561 characters (without spaces) or 293 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.